A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-014-2498-5
Published Online: 2014-06-07
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahn, Hee Kyung
Jung, Minkyu
Sym, Sun Jin
Shin, Dong Bok
Kang, Shin Myung
Kyung, Sun Young
Park, Jeong-Woong
Jeong, Sung Hwan
Cho, Eun Kyung
License valid from 2014-06-07